Bookhound

Primary

Books

Journals

Old Books

Theses

Catalogs

Bazaars

Fileservers

Online Services

Bookstores

FullText

⏬ ČDK❌ Archive.org❌ Crossref⏬ LibGen❌ CLEAR ALL

CROSSREF (MAX 100)

AuthorTitlePrint-PublishedTypeDOI@Sci-hub
CDKreference-entry10.1007/springerreference_92996
Functions of CDK/cyclin Complexes in Endoreplication Regulation by the CDK Inhibitor SIAMESEdissertation10.31390/gradschool_dissertations.5173
CDKreference-entry10.1007/springerreference_37256
Pandit, J.Novel CDK-5 inhibitors - crystal structure of inhibitor EFQ with CDK-22009/9/8dataset10.2210/pdb3igg/pdb
Pandit, J.Novel CDK-5 inhibitors - crystal structure of inhibitor EFP with CDK-22009/9/8dataset10.2210/pdb3ig7/pdb
Figure 4—figure supplement 1. CDK–phosphorylation of ORC intrinsically inhibits helicase loading.component10.7554/elife.33309.013
CDK Inhibitor R547reference-entry10.32388/iap5sl
Willighagen, Egon10000 CDK commits!posted-content10.59350/w1hpp-ks316
Willighagen, EgonCDK Literature #3posted-content10.59350/rkkty-a3w29
Willighagen, EgonCDK Newsposted-content10.59350/xf9bq-44218
CDKbook-chapter10.1007/3-540-30683-8_274
Willighagen, EgonCDK Literature #4posted-content10.59350/es4e7-esh15
Cermin Dunia Kedokteranjournal10.55175/cdk
CDK Inhibitor AT7519reference-entry10.32388/286jz0
CDK Gene Mutationreference-entry10.32388/kf9klo
Willighagen, EgonStatCVS on CDKposted-content10.59350/q7ehm-v1m81
Willighagen, EgonCDK Literature #1posted-content10.59350/g22fv-gtc07
CDKbook-chapter10.1007/978-3-540-47648-1_959
Hu, X.Cdc2: a monopotent or pluripotent CDK?2011/6journal-article10.1111/j.1365-2184.2011.00753.x
Willighagen, EgonCDK Literature #2posted-content10.59350/17nhx-htt54
Huang, LindaFaculty Opinions recommendation of Regulation of a cyclin-CDK-CDK inhibitor complex by inositol pyrophosphates.2007/4/23dataset10.3410/f.1080804.533727
Supplementary file 1. CDK sequences used for phylogenetic analysiscomponent10.7554/elife.10767.021
Willighagen, EgonNightly CDK builds now availableposted-content10.59350/s63wt-hbx56
Apodaca, Richard L.Updating Ruby CDKposted-content10.59350/yy9a2-wy148
Willighagen, EgonThe CDK data model #1posted-content10.59350/4xfms-7nn46
CDK Inhibitor SNS-032reference-entry10.32388/2sggcz
Willighagen, EgonCDK-Taverna fully recognizedposted-content10.59350/pk40z-7z702
cdkbook-chapter10.1007/3-540-29832-0_321
CDKbook-chapter10.1007/978-3-540-38918-7_5357
Willighagen, EgonCDK Module dependencies #2posted-content10.59350/e7qrk-ypg78
cdkbook-chapter10.1007/3-540-29719-0_321
Willighagen, EgonCDK Workshop - Day #2posted-content10.59350/f7vn0-kqz26
Schreiner, S.Kongenitale Kniegelenkluxation (CDK)2012/1journal-article10.1007/s00132-011-1874-7
Carnero, A.The INK4 Family of CDK Inhibitors1998book-chapter10.1007/978-3-642-71941-7_3
CDK Inhibitorsbook-chapter10.1007/978-3-540-47648-1_963
journal-issue10.55175/cdk.v48i6
Valk, ErvinCDK signaling via nonconventional CDK phosphorylation sites2023/11/1journal-article10.1091/mbc.e22-06-0196
Grigoroudis, Asterios I.Preparation of CDK/Cyclin Inhibitor Complexes for Structural Determination2016book-chapter10.1007/978-1-4939-2926-9_4
Alvira, DanielDrug Delivery Strategies of Chemical CDK Inhibitors2016book-chapter10.1007/978-1-4939-2926-9_12
Hu, ShanhuTargeting anaphase catastrophe through CDK inhibition in lung cancerdissertation10.1349/ddlp.1623
Degradation by Design: New Cyclin K Degraders from Old CDK Inhibitorscomponent10.1021/acschembio.3c00616.s002
journal-issue10.55175/cdk.v47i7
Willighagen, EgonSingle PDFs for CDK News articlesposted-content10.59350/rgdzb-bfe36
Willighagen, EgonJava Server Pages with CDK functionalityposted-content10.59350/3kvks-pdb73
Apodaca, Richard L.Ruby CDK for Newbiesposted-content10.59350/50ebs-4zq55
Willighagen, EgonCalculating geometrical properties with the CDKposted-content10.59350/sy6r5-pzw09
Willighagen, EgonAtom typing in the CDKposted-content10.59350/wm7aq-eqz10
CDK2011book-chapter10.1007/978-3-642-16483-5_959
CDK Inhibitory Proteinbook-chapter10.1007/3-540-30683-8_276
Apodaca, Richard L.CDK, the Ruby Wayposted-content10.59350/49w1p-2y164
Willighagen, EgonJumbo 5.0 and the CDKposted-content10.59350/y0mte-4ns18
Willighagen, EgonCDK close to entering Debianposted-content10.59350/dmspa-wyb25
CDK Inhibitors2011book-chapter10.1007/978-3-642-16483-5_963
journal-issue10.55175/cdk.v48i2
Gortat, AnnaAnalysis of CDK Inhibitor Action on Mitochondria-Mediated Apoptosis2016book-chapter10.1007/978-1-4939-2926-9_9
journal-issue10.55175/cdk.v47i11
CDK/JAK2/FLT3 Inhibitor TG02 Citratereference-entry10.32388/xklmgh
Willighagen, EgonThe CDK data classes and change notificationsposted-content10.59350/3xsm0-bt478
Willighagen, EgonCDK Workshop - Days #3 and #4posted-content10.59350/kvq10-snm07
CDK-Activating Kinase Assembly Factor MAT1reference-entry10.32388/6s4tbs
journal-issue10.55175/cdk.v49i0
Apodaca, Richard L.Scripting CDK with JRubyposted-content10.59350/sxxfq-shj88
Willighagen, EgonCDK Bug Squash Party - Day 5posted-content10.59350/paxbm-rac78
Willighagen, EgonCDK Bug Squash Party - Day 2posted-content10.59350/wzs4m-9ky43
Willighagen, EgonThe CDK/Metabolomics/Chemometrics Unconference resultsposted-content10.59350/f2ajz-tmr63
CDK2016book-chapter10.1007/978-3-662-46875-3_100468
Willighagen, EgonCDK and the Java 6 betaposted-content10.59350/6az21-1dt76
Willighagen, EgonJumbo 5.0 and CML support in CDKposted-content10.59350/dzvnw-3b413
Hirai, HiroshiEvaluating Chemical CDK Inhibitors as Cell Death Inducers2016book-chapter10.1007/978-1-4939-2926-9_14
Willighagen, EgonUML diagram of CDK module dependenciesposted-content10.59350/a3r1n-72841
journal-issue10.55175/cdk.v47i10
Willighagen, EgonCDK Bug Squash Party - Day 1posted-content10.59350/y5srm-hzx87
journal-issue10.55175/cdk.v48i4
Upton, Jason W.Evidence for CDK-Dependent and CDK-Independent Functions of the Murine Gammaherpesvirus 68 v-Cyclin2006/12/15journal-article10.1128/jvi.01722-06
Apodaca, Richard L.Porting MX - CDK-Compatible VF Implementationposted-content10.59350/xat1r-hcs92
Lacy, SusanIdentification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes1997/5/22journal-article10.1038/sj.onc.1201085
journal-issue10.55175/cdk.v47i8
journal-issue10.55175/cdk.v47i12
grant10.55776/tai3266225
journal-issue10.55175/cdk.v47i9
journal-issue10.55175/cdk.v48i5
journal-issue10.55175/cdk.v42i10
Ruiz, E. JosuéMeiotic Inactivation of Xenopus Myt1 by CDK/XRINGO, but Not CDK/Cyclin, via Site-Specific Phosphorylation2008/10journal-article10.1016/j.molcel.2008.08.029
Apodaca, Richard L.Scripting Molecular Fingerprints with Ruby CDKposted-content10.59350/xgf37-ggz21
Design, Synthesis, and Biological Evaluation for First GPX4 and CDK Dual Inhibitorscomponent10.1021/acs.jmedchem.3c01890.s002
Schneider, BrandtRole of the Cdk Inhibitor Sic 1 in Start1999/8/1report10.21236/ada378108
Guevara, TatianaEvaluating the Effects of CDK Inhibitors in Ischemia–Reperfusion Injury Models2016book-chapter10.1007/978-1-4939-2926-9_10
Degradation by Design: New Cyclin K Degraders from Old CDK Inhibitorscomponent10.1021/acschembio.3c00616.s001
Schneider, BrandtRole of the Cdk Inhibitor Sic 1 in Start2000/9/1report10.21236/ada392485
Apodaca, Richard L.CDK, the Ruby Way: RCDK-0.2.0posted-content10.59350/ev966-zz940
journal-issue10.55175/cdk.v48i1
journal-issue10.55175/cdk.v48i3
Guha, Rajarshircdk: Interface to the 'CDK' Libraries2006/10/4dataset10.32614/cran.package.rcdk
Design, Synthesis, and Biological Evaluation for First GPX4 and CDK Dual Inhibitorscomponent10.1021/acs.jmedchem.3c01890.s003
Lee, Young-SamRegulation of a Cyclin-CDK-CDK Inhibitor Complex by Inositol Pyrophosphates2007/4/6journal-article10.1126/science.1139080
GROTH, AHigh-density growth arrest in Ras-transformed cells: low Cdk kinase activities in spite of absence of p27 Cdk-complexes2005/9journal-article10.1016/j.cellsig.2004.11.021
Design, Synthesis, and Biological Evaluation for First GPX4 and CDK Dual Inhibitorscomponent10.1021/acs.jmedchem.3c01890.s001
Gallastegui, EdurneImmunoprecipitation of Cdk–Cyclin Complexes for Determination of Kinase Activity2016book-chapter10.1007/978-1-4939-2926-9_1
Design, Synthesis, and Biological Evaluation for First GPX4 and CDK Dual Inhibitorscomponent10.1021/acs.jmedchem.3c01890.s004
Cyclin-dependent Kinase (CDK) Inhibitorbook-chapter10.1007/3-540-30683-8_390
Willighagen, EgonCDK 1.0: a milestone after 7 year of developmentposted-content10.59350/qd21w-71g30
Fisher, Robert PFaculty Opinions recommendation of Meiotic inactivation of Xenopus Myt1 by CDK/XRINGO, but not CDK/cyclin, via site-specific phosphorylation.2008/11/11dataset10.3410/f.1125916.583024
Apodaca, Richard L.Drawing 2-D Structures with Structure-CDKposted-content10.59350/qxc8d-c1w35
Gangopadhyay, AditiThe Prospects of CDK Targeting and Clinical Application of CDK Inhibitors in Cancer2018/12/5book-chapter10.2174/9781681087016118090008
Schneider, BrandtRole of the Cdk Inhibitor Sic 1 in Start1998/8/1report10.21236/ada359281
lavarone, AntonioRepression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p151997/5journal-article10.1038/387417a0
Willighagen, EgonThe molecular QSAR descriptors in the CDKposted-content10.59350/47rre-wwc20
Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk)component10.1021/acschembio.7b00972.s002
Chiarelli, CCyclin D, CDK and CDK Inhibitors in Melanocytic Neoplasms.1997/8journal-article10.1097/00000372-199708000-00072
Willighagen, EgonInChI's in LaTex and CDK Newsposted-content10.59350/hysd0-wvc09
-, -Indeks Subjekjournal-article10.55175/cdk.v49i2.1746
Willighagen, EgonTest results for the CDK 1.0.x branchposted-content10.59350/ry980-qya21
Pérez-Benavente, BeatrizCell Synchronization Techniques to Study the Action of CDK Inhibitors2016book-chapter10.1007/978-1-4939-2926-9_8
Willighagen, EgonCDK Debug classes and fixing the ModelBuilder3D bugposted-content10.59350/6p49t-sj396
Synthesis of benzofuropyridine derivatives as CDK-5 inhibitors and anticancer agentsdissertation10.58837/chula.the.2022.1218
CDKother10.1002/0471684228.egp01945
Guha, Rajarshircdklibs: The CDK Libraries Packaged for R2009/1/8dataset10.32614/cran.package.rcdklibs
Willighagen, EgonCDK News 2.3 and InChI'sposted-content10.59350/z97vw-87009
Multiplexed Profiling of CDK Kinase Activities in Tumor Biopsies with Fluorescent Peptide Biosensorscomponent10.1021/acssensors.4c00139.s001
Willighagen, EgonCDK Bug Squash Party - Day 3 and 4posted-content10.59350/zwkym-aty79
Figure 3: The efficiency of tumor markers in distinguish CDK patients from healthy control.component10.7717/peerj.19240/fig-3
grant10.55776/t393
-, -Indeks Penulisjournal-article10.55175/cdk.v48i12.1586
-, -Indeks Subjekjournal-article10.55175/cdk.v48i12.1589
Many Hats for Cdk Inhibitor2006/1/10journal-article10.1126/stke.3172006tw468
Willighagen, EgonR/CDK install fails on GCC 4.0 systemsposted-content10.59350/b1vyj-0kd63
Palomino-Schätzlein, MartinaMetabolomic Applications to the Characterization of the Mode-of-Action of CDK Inhibitors2016book-chapter10.1007/978-1-4939-2926-9_16
Futcher, A. B.General Methods for Identifying G1-phase Substrates of Cdk Protein Kinases1999/6/1report10.21236/ada374137
CDK2008book-chapter10.1007/978-1-4020-6754-9_2580
-, -Indeks Penulisjournal-article10.55175/cdk.v49i2.1745
Willighagen, EgonJanocchio: Jmol and CDK based 1H coupling constant predictionposted-content10.59350/rxzh8-9yr48
Willighagen, EgonCDK is now available from your nearest Debian mirrorposted-content10.59350/g5s78-zqk90
grant10.35802/065956
Tsutsui, TaikiIdentification of target genes for the CDK subunits of the Mediator complex2011/12journal-article10.1111/j.1365-2443.2011.01565.x
Guidato, SoniaCyclin D2 Interacts with cdk‐5 and Modulates Cellular cdk‐5/p35 Activity1998/1journal-article10.1046/j.1471-4159.1998.70010335.x
-, -Indeks Subjekjournal-article10.55175/cdk.v49i1.1648
CDK Inhibitors, Endocrine Therapy for Male Patients With Breast Cancer2019/3/8dataset10.1200/adn.19.190134
Dutto, IlariaAssessing Cell Cycle Independent Function of the CDK Inhibitor p21CDKN1A in DNA Repair2016book-chapter10.1007/978-1-4939-2926-9_11
-, -Indeks Akhir Tahunjournal-article10.55175/cdk.v48i12.1588
-, -Indeks Penulisjournal-article10.55175/cdk.v49i1.1647
Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk)component10.1021/acschembio.7b00972.s001
Nishizawa, MasafumiMouse Cyclin-dependent Kinase (Cdk) 5 Is a Functional Homologue of a Yeast Cdk, Pho85 Kinase1999/11journal-article10.1074/jbc.274.48.33859
CELL CYCLE-REGULATION OF THE FANCD2 PROTEIN VIA CDK-MEDIATED S592 PHOSPHORYLATIONdissertation10.23860/thesis-cantres-velez-juan-2020
Willighagen, EgonComparing JUnit test results between CDK trunk/ and a branchposted-content10.59350/zs3tv-pp865
Willighagen, EgonOpen Source Java tool chain: CDK compiles and JUnit tests runposted-content10.59350/933ah-c7f36
Figure 7. Model of how meiotic cells inhibit DNA replication during the MI–MII transition.component10.7554/elife.33309.026
Willighagen, EgonModern chemistry in the CDK: beyond the two-atom bondposted-content10.59350/h2ytc-6pt51
Apodaca, Richard L.Source Code Documentation in Ruby: RDoc for Ruby CDKposted-content10.59350/jf1hb-6ev38
Willighagen, EgonProtein support in Bioclipse using Jmol and the CDKposted-content10.59350/23wn4-1nt07
Lone, WaseemSilicon-tethered colchicine aryne cyclo-adduct as a potent molecule for the abrogation of epithelial to mesenchymal transition via modulating cell cycle regulatory CDK-2 and CDK-4 kinasesposted-content10.26434/chemrxiv-2024-rs3lh
Apodaca, Richard L.From IUPAC Name to Molecular Formula with Ruby CDKposted-content10.59350/1nn38-3ef94
Zettelmeyer, FlorianCDK Digital Marketing: Addressing Channel Conflict with Data Analytics2014reference-book10.4135/9781473969650
Willighagen, EgonTrouble running the CDK JUnit tests with Cacao and Kaffeposted-content10.59350/rn78z-r7j37
Shimotohno, AkieCDKPhosphorylationother10.1002/9781119312994.apr0336
Apodaca, Richard L.MX Performance Comparison #3: Substructure Search in MX and CDKposted-content10.59350/n4y52-t3a30
Apodaca, Richard L.Agile Chemical Informatics Development with CDK and Ruby: RCDK-0.3.0posted-content10.59350/c8h7w-n4922
Protein kinase (CDK/MAK)book-chapter10.1007/978-3-540-49756-1_63
Purnamasari, Maretta RosabellaIktiosis Vulgarisjournal-article10.55175/cdk.v47i10.1085
Futcher, A. B.General Methods for Identifying Gl-phase Substrates of Cdk Protein Kinases.1998/6/1report10.21236/ada366953
Ringer, LymorRole of p53 in cdk Inhibitor VMY-1-103-induced Apoptosis in Prostate Cancer2013/11/1report10.21236/ada592440
Anurogo, DitoCancer Stem Cellsjournal-article10.55175/cdk.v48i11.1549
Review for "ALG3 contributes to the malignant properties of OSCC cells by regulating CDK‐Cyclin pathway"2020/8/16peer-review10.1111/odi.13687/v1/review1
Review for "ALG3 contributes to the malignant properties of OSCC cells by regulating CDK‐Cyclin pathway"2020/8/17peer-review10.1111/odi.13687/v1/review2
Cyclin-Dependent Kinase (CDK) Inhibitors: StructureActivity Relationships and Insights into the CDK2 Selectivity of 6Substituted 2Arylaminopurinescomponent10.1021/acs.jmedchem.6b01254.s001
EMPIAR dataset10.6019/empiar-10438
Shimotohno, AkieCDK Phosphorylationbook-chapter10.1002/9780470988923.ch5
Prasetya, DamarVarisela Neonataljournal-article10.55175/cdk.v47i12.1239
Cyclin-Dependent Kinase (CDK) Inhibitors: StructureActivity Relationships and Insights into the CDK2 Selectivity of 6Substituted 2Arylaminopurinescomponent10.1021/acs.jmedchem.6b01254.s002
Apodaca, Richard L.From SMILES to InChI: Rino, CDK, and Ruby Java Bridgeposted-content10.59350/hra9n-qry69
Pohl, M.GWK/CDK-Bank1994/1/1book-chapter10.4337/9781781954218.00152
Dutta, AnindyaAction of the p53 Effector, p2l, on its Targets: Cyclin cdk and PCNA1998/10/1report10.21236/ada368460
Apodaca, Richard L.Easily Calculate TPSA Descriptors from SMILES Strings Using Ruby CDKposted-content10.59350/8xxp3-b8077
Roovers, KristinRole of Cyclin D1 and cdk Inhibitors in Breast Cancer Pathogenesis2002/5/1report10.21236/ada407447
Apodaca, Richard L.MX Performance Comparison #2: Exhaustive Ring Perception in MX and CDKposted-content10.59350/tv70e-5c238
Ringer, LymorRole of p53 in cdk Inhibitor VMY-1-103-Induced Apoptosis in Prostate Cancer2012/9/1report10.21236/ada567635
Rusli, RichardoRetinitis Pigmentosajournal-article10.55175/cdk.v47i7.597
Durandau, EricCross-regulation between CDK and MAPK control cellular fateposted-content10.1101/274787
Kawauchi, TakeshiExtra‐cell cycle regulatory functions of cyclin‐dependent kinases (CDK) and CDK inhibitor proteins contribute to brain development and neurological disorders2013/3journal-article10.1111/gtc.12029
Yu, BoDownregulation of Cyclin D1 Alters cdk 4- and cdk 2-Specific Phosphorylation of Retinoblastoma Protein2000/6journal-article10.1006/mcbr.2000.0238
Cheng, WeiyanRecent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures2019/2journal-article10.1016/j.ejmech.2019.01.003
Nishizawa, MasafumiPhosphorylation of Sic1, a Cyclin-dependent Kinase (Cdk) Inhibitor, by Cdk Including Pho85 Kinase Is Required for Its Prompt Degradation1998/9journal-article10.1091/mbc.9.9.2393
., SukamtoPenanganan Ketoasidosis Diabetik pada Anakjournal-article10.55175/cdk.v49i9.2039
Cyclin dependent kinase (CDK)2010/11journal-article10.1038/scibx.2010.1319
Cyclin-Dependent Protein Kinases (CDK)2008book-chapter10.1007/978-1-4020-6754-9_3981
CDK2006book-chapter10.1007/3-540-29623-9_10003
Apodaca, Richard L.Open Benchmarks for Cheminformatics: First Performance Comparison Between CDK and MXposted-content10.59350/7nc6k-w4216
Cyclin‐Dependent Protein Kinase ( CDK )other10.1002/0471684228.egp02997
Srivastava, MansiLineage-specific CDK activity dynamics characterize early mammalian developmentposted-content10.1242/prelights.38013
Lawrenti, HastaritaHemofilia dan Perkembangan Terapinyajournal-article10.55175/cdk.v48i9.1496
Figure 4: The efficiency of tumor markers in distinguish CDK patients with normal serum creatinine from healthy controls.component10.7717/peerj.19240/fig-4
Katz, MaxRichFaces CDK: Building Custom Components2011book-chapter10.1007/978-1-4302-3450-0_14
Wysocki, RobertCDK Pho85 targets CDK inhibitor Sic1 to relieve yeast G1 checkpoint arrest after DNA damage2006/10journal-article10.1038/nsmb1139
Review for "ALG3 contributes to the malignant properties of OSCC cells by regulating CDK‐Cyclin pathway"2020/10/7peer-review10.1111/odi.13687/v2/review1
Mahendra, CiptaPeutz-Jeghers Syndromejournal-article10.55175/cdk.v48i12.1574
Pérez-Hidalgo, LiviaCDK Inhibitors2013book-chapter10.1007/978-1-4419-9863-7_12
Apodaca, Richard L.From InChI to Image with Ruby Open Babel and Ruby CDKposted-content10.59350/r891p-vmx14
Yuliana, JeniAspek Klinis Ambliopiajournal-article10.55175/cdk.v49i1.1639
Apodaca, Richard L.Cheminformatics for the Web: Convert SD Files to HTML with Ruby CDKposted-content10.59350/gvwgq-b0x50
Sanchez-Diaz, AlbertoThe Mitotic Exit Network and Cdc14 phosphatase initiate cytokinesis by counteracting CDK phosphorylations and blocking polarised growth2012/8/29journal-article10.1038/emboj.2012.224
Teo, GloriaDiagnosis dan Tatalaksana Kegawatdaruratan Hiperkalemiajournal-article10.55175/cdk.v48i8.1447
Application of Biocatalytic Reductive Amination for the Synthesis of a Key Intermediate to a CDK 2/4/6 Inhibitorcomponent10.1021/acs.oprd.1c00255.s001
Lawrensia, SherlyDiagnosis dan Tatalaksana Artritis Tuberkulosisjournal-article10.55175/cdk.v47i8.773
Chandra, RudiTatalaksana Melanoma Maligna Kutaneusjournal-article10.55175/cdk.v48i7.1453
RAYNAL, SDIFFERENTIAL-EFFECTS OF TRANSFORMING GROWTH-FACTOR-BETA-1 ON PROTEIN-LEVELS OF P21 WAF AND CDK-2 AND ON CDK-2 KINASE-ACTIVITY IN HUMAN RD AND CCL64 MINK LUNG-CELLSjournal-article10.3892/ijo.7.2.337
Aprelikova, OlgaBoth p16 and p21 Families of Cyclin-dependent Kinase (CDK) Inhibitors Block the Phosphorylation of Cyclin-dependent Kinases by the CDK-activating Kinase1995/8journal-article10.1074/jbc.270.31.18195
Fig. 1. Ovarian enlargement and lack of blood flow in the CDK regimen with a full bladdercomponent10.17816/psaic575-154
Ogata, RyoheiResistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells2021/1journal-article10.1007/s12282-020-01150-8
Nitiyoso, NugrohoAspek Imunitas pada COVID-19journal-article10.55175/cdk.v48i9.1497
., SuhartoFisioterapi Kasus Cerebral Palsy Kuadriplegia Spastikjournal-article10.55175/cdk.v49i9.2036
Lawrensia, SherlyLung Abscess: Diagnosis and Treatmentjournal-article10.55175/cdk.v48i5.1373
Turner, N.Targeting the CDK 4-6 pathway2019/3journal-article10.1016/s0960-9776(19)30078-5
When a CDK Is Really a Transcription Factor2005/1/11journal-article10.1126/stke.2662005tw14
Prasetio, AdrianGangguan Psikiatri Terkait Kafeinjournal-article10.55175/cdk.v47i7.603
grant10.55776/p19894
Febriana, LydiaSuplemen untuk Terapi Obesitasjournal-article10.55175/cdk.v49i0.1964
Nitiyoso, NugrohoPilihan Pengobatan Sistemik pada Psoriasisjournal-article10.55175/cdk.v49i3.1775
Lone, Waseem IqbalDiscovery of Colchicine Aryne Cyclo-Adduct as a Potent Molecule for the Abrogation of Epithelial to Mesenchymal Transition Via Modulating Cell Cycle Regulatory Cdk-2 and Cdk-4 Kinasesposted-content10.2139/ssrn.4814175
Fauzi, AhmadHaglund Deformity: Diagnosis and Treatmentjournal-article10.55175/cdk.v49i10.2067
Yahya, WillyRetinopati Prematuritas : Diagnosis dan Tatalaksanajournal-article10.55175/cdk.v47i10.1080
EMPIAR dataset10.6019/empiar-10561
Dai, YunCDK Inhibitors in Multiple Myeloma2008book-chapter10.1007/978-1-59745-564-0_22
Henri, P.Psoriatic epidermis is associated with upregulation of CDK 2 and inhibition of CDK 4 activity2020/3journal-article10.1111/bjd.18178
Cyclin dependent kinase (CDK)2010/3journal-article10.1038/scibx.2010.272
Futcher, A. B.General Methods for Identifying G1-Phase Substrates of Cdk Protein Kinases.1996/6/1report10.21236/ada323678
Cyclin dependent kinase (CDK)2012/4journal-article10.1038/scibx.2012.385
p27 Kip1−/− Strain 32001/10/3journal-article10.1126/sageke.2001.1.tg10
Meijer, LaurentCDK Inhibitors2002book-chapter10.1016/b978-012476249-7/50008-4
Bisbis, BadiaCyclin-dependent Kinase (CDK) Inhibitors Regulate the CDK-Cyclin Complex Activities in Endoreduplicating Cells of Developing Tomato Fruit2006/3journal-article10.1074/jbc.m506587200
Karyadi, ErlindaCutaneous Mucormycosisjournal-article10.55175/cdk.v49i2.1740
Larochelle, StéphaneCDK-Activating Kinases: Detection and Activity Measurementsbook-chapter10.1385/1-59259-857-9:279
Putri, Zanty RakhmaniaBell’s Palsy: Diagnosis dan Tatalaksanajournal-article10.55175/cdk.v49i8.1986
Pricelda, AliciaTren Terapi Age-Related Macular Degenerationjournal-article10.55175/cdk.v48i12.1584
Lukito, Johan IndraTinjauan atas Terapi Insulinjournal-article10.55175/cdk.v47i9.917
Cicenas, JonasCDK Inhibitors and FDA: Approved and Orphanjournal-article10.3390/cancers16081555
Müllers, ErikCdk activity drives senescence from G2 phaseposted-content10.1101/041723
Karyadi, ErlindaCutaneous Mucormycosisjournal-article10.55175/cdk.v49i2.1726
Chandra, RudiPilihan Pengobatan Dermatologis Penuaan Periorbitaljournal-article10.55175/cdk.v47i12.1241
Morgan, David O.Principles of CDK regulation1995/3journal-article10.1038/374131a0
Mahendro, Della SulamitaPenggunaan Antivirus untuk COVID-19journal-article10.55175/cdk.v48i7.1459
Kristiningrum, EstherPenggunaan Hydroxychloroquine dalam Tatalaksana Covid-19journal-article10.55175/cdk.v47i12.1246
Suryani, AdeliaFaktor-Faktor yang Memengaruhi Pigmentasi Manusiajournal-article10.55175/cdk.v47i11.1195
Permasutha, Made BayuTinjauan atas Kanker Rongga Mulutjournal-article10.55175/cdk.v48i3.1327
Afifah Nurullah, FitriTinjauan atas N-Nitrosodimethylamine (NDMA)journal-article10.55175/cdk.v47i12.1249
p27 Kip1−/− Strain 22001/10/3journal-article10.1126/sageke.2001.1.tg9
Dai, YunCDK Inhibitors in Leukemia and Lymphoma2019/9/17book-chapter10.1201/9780429114670-15
-, TommyAngina Prinzmetal - Diagnosis dan Tatalaksanajournal-article10.55175/cdk.v48i6.1431
Kusumo, Inosensia DiajengTinjauan Atas Piodermajournal-article10.55175/cdk.v49i4.1822
CDK Inhibitor Triples PFS in Breast Cancer2013/1/1journal-article10.1158/2159-8290.cd-nb2012-149
ASCO TAPUR, CDK Studies Endeavor to Fill Gaps in Personalized Cancer Care Research2024/12/1dataset10.1200/acon.24.00037
Apodaca, Richard L.CampDepict: Building a Simple SMILES Depict Web Application With JRuby, Structure CDK, and Campingposted-content10.59350/d2m6v-tag27
Johan, MichaelEvaluasi dan Tatalaksana Hipernatremiajournal-article10.55175/cdk.v48i6.1441
Palacios Blanco, InésCDK phospho-regulation of the Rad51-accessory factor Sfr1 and its role in meiotic recombinationdissertation10.14201/gredos.161088
Decision letter: CDK-regulated dimerization of M18BP1 on a Mis18 hexamer is necessary for CENP-A loading2016/12/19peer-review10.7554/elife.23352.021
Stanley, Jone A.Chromium-VI arrests cell cycle and decreases granulosa cell proliferation by down-regulating cyclin-dependent kinases (CDK) and cyclins and up-regulating CDK-inhibitors2011/7journal-article10.1016/j.reprotox.2011.05.007
Fanardy, AngelineToksin Botulinum untuk Kasus Urogenitaljournal-article10.55175/cdk.v48i3.1337
Dinari, Nur AlfiMiopia: Etiologi dan Terapijournal-article10.55175/cdk.v49i10.2069
Ciatawi, KartiniPatofisiologi Spinal Cord Injuryjournal-article10.55175/cdk.v49i5.1848
Ciatawi, KartiniPatofisiologi Spinal Cord Injuryjournal-article10.55175/cdk.v49i9.2032
-, CarlsonTatalaksana Demam pada Anakjournal-article10.55175/cdk.v47i11.1200
Booth, J. G.Magnetic Susceptibilities of B.C.C. Cr-Rh, Cr-Ru, Cr-Re, and Cr-Os Alloys1964/12/31book-chapter10.1515/9783112497081-038
EMPIAR dataset10.6019/empiar-10431
Mueller, DanielAbstract 2821: Characterization of CDK inhibitors in a biochemical assay using a comprehensive panel of human CDK-cyclin complexes2016/7/15journal-article10.1158/1538-7445.am2016-2821
Irsyada Yusuf, AmryDiagnosis dan Tatalaksana Kriptorkhismusjournal-article10.55175/cdk.v48i3.1330
Wijaya, MeiliyanaMeningitis Kriptokokus pada Penderita HIVjournal-article10.55175/cdk.v48i1.1256
Setiawan, MichaelMielopati Non Kompresif: Pendekatan Diagnosisjournal-article10.55175/cdk.v47i9.909
Dewi, Nadia PuspaAspek Klinis Dermatitis Seboroikjournal-article10.55175/cdk.v49i6.1881
Wijaya, SandyDiagnosis dan Tatalaksana Polisitemia Verajournal-article10.55175/cdk.v47i7.596
Lawrenti, HastaritaPenghambat Immune Checkpoint untuk Terapi Kankerjournal-article10.55175/cdk.v49i0.1966
Shamsi, ZahraConcestor kinase activation mechanism uncovers the cyclin dependence of CDK family kinasesposted-content10.1101/410902
Cherub, JaneTerapi Antikoagulan pada COVID-19journal-article10.55175/cdk.v48i6.1436
Lukito, Johan IndraGunakan Insulin dengan CERMATjournal-article10.55175/cdk.v47i10.1093
Renita Sanyasi, Rosa De LimaSindrom Mona Lisajournal-article10.55175/cdk.v48i1.1258
p27 Kip1−/− Strain 12001/10/3journal-article10.1126/sageke.2001.1.tg8
Carrieri, Francesca AnnaCDK 1 and CDK 2 regulate NICD 1 turnover and the periodicity of the segmentation clock2019/7journal-article10.15252/embr.201846436
Besser, AlexandraCDK Inhibitors in Normal and Malignant Cells2023book-chapter10.1016/b978-0-12-821618-7.00221-2
Mahendrakrisna, DanielTatalaksana Epilepsi Refrakterjournal-article10.55175/cdk.v47i9.911
Feinberg, Bruce A.Prescribing preferences for hormone sensitive (HR+) metastatic breast cancer (mBC) in the CDK 4/6 inhibitor (CDK 4/6i) era.2020/5/20journal-article10.1200/jco.2020.38.15_suppl.e13058
Dianky, AmandaPeran Nutrigenomik pada Tata Laksana Obesitasjournal-article10.55175/cdk.v49i0.1965
Decision letter: CDK control pathways integrate cell size and ploidy information to control cell division2020/12/20peer-review10.7554/elife.64592.sa1
Wijaya, LupitaTatalaksana Nyeri Neuropatik Perifer dengan Sediaan Patchjournal-article10.55175/cdk.v48i9.1484
Tan, ChristineTrombosis pada Pasien COVID-19journal-article10.55175/cdk.v48i12.1571
4-Arylazo-3, 5-diamino-1H-pyrazole CDK Inhibitors: SAR Study, Crystal Structure in Complex with CDK2, Selectivity, and Cellular Effectscomponent10.1021/jm0605740.s001
Specification for Electric Fusion-Welded Ni-Cr-Co-Mo Alloy, Ni-Fe-Cr-Si Alloy, Ni-Cr-Fe-Al Alloy, Ni-Cr-Fe Alloy, and Ni-Cr-Fe-Si Alloy Pipestandard10.1520/b0546-19r24
Ratna Sari, Ihda ZuyinaGambaran Sistiserkosis dan Taeniasisjournal-article10.55175/cdk.v49i3.1768
CRESCENZI, ELVIRAAssociation of Bcl‐2 with Cyclin A/Cdk‐2 Complex and Its Effects on Cdk‐2 Activity2002/11journal-article10.1111/j.1749-6632.2002.tb04647.x
First CDK 4/6 Inhibitor Heads to Market2015/4/1journal-article10.1158/2159-8290.cd-nb2015-028
Mahendra, CiptaTerapi Berbasis Sel: Perkembangan Terkinijournal-article10.55175/cdk.v49i3.1769
Clinical Trial in Healthy Volunteers and Subjects With CDKjournal-article10.31525/ct1-nct03893799
Cyclin dependent kinase (CDK); p532012/10journal-article10.1038/scibx.2012.1028
Falco, Giulia DeCdk Inhibitors: Background and Introductionbook-chapter10.1385/1-59259-401-8:01
Decker, TCell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p272002/3/1journal-article10.1038/sj.leu.2402389
Mostafa, Heba H.Herpes Simplex Virus 1 Upregulates p35, Alters CDK-5 Localization, and Stimulates CDK-5 Kinase Activity during Acute Infection in Neurons2015/5journal-article10.1128/jvi.00106-15
Sondhi, Sham M.Synthesis, anti-inflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/benzoxazole derivatives and some Schiff’s bases2006/6journal-article10.1016/j.bmc.2006.01.054
Grant, StevenCDK inhibitors and immune responses2009/8/15journal-article10.4161/cc.8.16.9346
Chandra, RudiAspek Dermatologi Penuaan Kulit Periorbitaljournal-article10.55175/cdk.v47i9.920
-, CecileDiagnosis dan Tatalaksana Paroxysmal Nocturnal Hemoglobinuriajournal-article10.55175/cdk.v48i7.1452
-, FilbertoDiagnosis dan Tatalaksana Congenital Talipes Equino Varus (CTEV)journal-article10.55175/cdk.v48i1.1270
Bird, R.CurtisThe Cyclin/Cyclin-Dependent Kinase (cdk) Complex1997book-chapter10.1016/b978-012100160-5/50006-3
A novel and robust molecular switch actuating the quantitative model of eukaryotic Cdk controlproceedings-article10.18699/sbb-2022-104
Luminturahardjo, WinarkoPeranan Probiotik dalam Penanganan Infeksi COVID-19journal-article10.55175/cdk.v48i5.1371

Archive (6)

TitleDescriptionPublishedAdded
CIA Reading Room cia-rdp70-00058r000200100098-1: PUZZLING FOREIGN POLICY OF THE U.S.FE.B. 1 51962 Approved For Release 1999/09/'-pQ1 .RDP7 United 8tates'T e ro ruby die has rdad in. hiai iodal ,which goes MO A,maxrlcan w psper. head-- haq~_ Cominunlat lined' :"Vtl~ e d ti 4!- .,stay' cra* e iA- OOMDgiW11'k .. Cdk ? bif thin M4 Ctrants: : thy; ''zi ,e4 tent to foreigh.*ld' anti the Congo Leader:' it erptains ywQ s trong atfr pe Vol" of,A oa Yet the "iJnlt d gat- ' t d f th o re e e o .policies which go along with former . Batista government this vast pone, do. Tf a c$dl 1'9 goal di et .4 Yr t 1 1e pt Victory' )endue B +dk a ltfiil Q d ve tIs at gC'tbe ' muiifng ta11i fir .. < ;thd words et etc. have speeches ' men. _~ e "l ode ?tSat~ snatchesf h p_oeeibie' 14%, Dim kTuubaff~ ~*ent-in the T?os rte 's, the l" rnm #? ant i~ic tltt~aoty.. Vital, i o s e a slat t[1gli,~ ? f i'q~M,' Cato ndgixe ex+~ e s 1$ o bf t 1+ . 'e dl 'iral o 1, + # < Uride*rstar-dstr,~ Ikrta eager ~e~ e td l t ' :thew le' n logs ,tn ezontinq otii rj~Y .# tiYea rioltcy a it izas ttt-t era:.+1e tie; era;19622023-08-06T09:52:48Z
CIA Reading Room cia-rdp80-00810a000600660006-7: RAILROAD COAL STOCKS AND STATUS OF RAILROAD CARS25X1 ApFrP 1 1t aXe amn~/j : CIA-RDP80-0081 OA0006006600 6-7 25I I CENTRAL I 25XIEPORT NO, L INFORMATION REPORT CD NO. COUNTRY Iket Cary SUBJECT Rail.rocd Cool Stockal and Statu?s of Railrord Coro 25X1 PLACE .CQU1'? ECG )ATE CF INFO. T a, OOCU!,-V 3T COOTASNS Ili POP.D1IT4OF1 A"ACTINOTHE NATIONAL lib FEN1R P.'' O8 T141 UHi 1ZD STATES, tIT:lmf1 THE HBANIUIG OF TITLE 28. SFr TIGHS 703 I! i -D 794. 0: THE U. S. CODE, A.3 ASSEH050. IT5 TAAHSIiISSION ~)4I Rd1:EL? I' OI> OF 415 C0RT01470 TD O:7 RECEIPT ay AH UNAUTHOTIIZED PE100.0 f TS ":' mUl GIT D DY AV THE REPRODU70-t OP ':'H1S FORA IS PR-IuIIIITED. 25X1 25X1 Coal stocks and ;onsurr Lion of coal :I: ca o pe ua ~,.- l' ti Date in Hard Coal Raw E oT>r Jam-ary Coal `iota::. 21 49,131 17,280 Stocks 22 48,028 17,191 46,668 18,043 }3 } 25 25X1 DA FE 16)),c-TW 9 April 3.953 NO. OF Fii=GES NJO.. OF G--'1 CLS, {LUSTED E..iL(1'r!} #3:+L1: `ENT y~ y.f REPORT NO. THIS IS UNEJ''ELUAliTD !1[,,i'OP Q 61\14Oii ;+ c$Z? ? ttc 3~ 76,6ci 78,0313 76,724, 2%::,;19532024-02-24T10:38:21Z
yahoo-groups-2018-05-23T11-49-52Z-c80acbYahoo! Groups API grab. Contains messages of the following groups: 3grupthk 6thbarnehurstbrownies abstinence_asexual_celibacy_group acl-deficient-knee adihusada admusa21_team30708 adora_permata_blok_8 apiswc_student_group ar0621history2 arak_sharif arg-l astra_it atlas_copco_people ba101_tfq bangocc_physician bdstudents_eee bestgift4christmas biwriting bordons_from_melina bphy brigade21 brissyuniforms bruno-henrique64 bscs3_cdk bscs_tritu_thesis1 bsing_unp bssef07m capebicol cdex_committee cgucoral choducmalo comingfuture_managers comissao_cult_igce coooooooooooooooooolllllllllll csci02_ama csci30cm_ama cse2009_brecw csoprocalliance dateadvisors dc3d deadseamineral dhe_shemobile dwdms dyfs econ121_unleashed edge_105 emoprinces erabptech exb4itmdungun extraincome_01 fashion_pants_cool friends_dhaka fte_uki97 furnimart gaurisa_lcw gaurisa_metadata gbi-r8 gliacompetenceconnect global_entrepreneurship_network groupepfti2_de_liut grow-community gschool161 hanover_park_mayor2009 highlandspor;2018-05-23T11:50:00Z
Various Artists * 33,333 Steps To A Power Ov The Darkness LeaguesVarious Artists * 33,333 Steps to a Power ov the Darkness Leagues   (Disc one)   01. DJ R3V3R3ND MURD3R * !33,333 STEPS TO A POWER OV THE DARKNESS LEAGUES!  02. sOuL_sCientiSt * More Fiyah Mix   03. FIGURATIVE THEATRE * MEGAMARKET UTOPIA   04. Hel.Razor * Slave 2 The System  05. dreDDup * We Fuck Until Dawn  06. Moray Eel * Hellish Adoption   07. Cryogenic Implosion * Delete Humanity   08. The Apocryphal Order * Beyond The Depraved Scope Of Salvation  09. Come To My Rise * Play A Game  10. The Rinn * Voices  11. Crimson Blue * L.M.A.  12. Severed Fifth * Blackening   13. Spiritual Dissection * Across A Frozen Hell  14. Returning We Hear the Larks * Nascence in the Caverns of Mount Olympus  15. Cuntworm * Seduced By Damnation  16. Earslaughter * Roka Smrti   (Disc two)     01. DiSloCaTed * Megazord  02. Cyber Snake * War  03. Circlerun * 13  04. Obsidian Shell * Misanthropia  05. Dawn Of Tears * Since They're Gone   06. Operación Mutante * Matanza  0;20132013-11-26T13:29:39Z
Crazy Bytes #04 (4 CD Set)Looking for old abandonware warez CD ISO's - If you have any not in my collection please contact me (pascal_of_irate @ hotmail . com). I can remove any copy protections from them (if required) and repost cracked versions for the community to enjoy. I am especially interested in CD's from the likes of Blobby International, Playdoh, Voodoo, Ghost, Tango, Delta, USA, Gold, Redhot, Jurassic, Pepsi, Alkey, Capaccino, Coke, Total, Razor, Xenon etc. but also any others from this era. Please see our special requests as the bottom of this page. Coming soon File: CrazyBytes_04_CD1.iso SHA1: 02a0e3c66323a6cfb2ef7c171d9fb061a260ba14 File: CrazyBytes_04_CD2.iso SHA1: 65c9a1f58b87c4dd304decd6e1a8d3c0c8f2a5a1 File: CrazyBytes_04_CD3.iso SHA1: 8071596c237b3c2135cc7910fd2c3aec79e26122 File: CrazyBytes_04_CD4.iso SHA1: 08b63b01c9ae25e23b9476dcc788251d6ea81764 Special request if you have any of these CD's please contact us: Blobby #04 , #05 , #44 Onyx DVD #01 - November 2001 (Password: oynxdvd4youreyeson;2023-03-13T02:11:51Z
RNA-seq analysis identifies an intricate regulatory network controlling cluster root development in white lupin.This article is from BMC Genomics , volume 15 . Abstract Background: Highly adapted plant species are able to alter their root architecture to improve nutrient uptake and thrive in environments with limited nutrient supply. Cluster roots (CRs) are specialised structures of dense lateral roots formed by several plant species for the effective mining of nutrient rich soil patches through a combination of increased surface area and exudation of carboxylates. White lupin is becoming a model-species allowing for the discovery of gene networks involved in CR development. A greater understanding of the underlying molecular mechanisms driving these developmental processes is important for the generation of smarter plants for a world with diminishing resources to improve food security. Results: RNA-seq analyses for three developmental stages of the CR formed under phosphorus-limited conditions and two of non-cluster roots have been performed for white lupin. In total 133,045,174 high-quality pa;20142014-10-21T21:50:41Z